*Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China; †Department of Dermatology, The Second Affiliated Hospital of Nantong University, Nantong, China.
Dermatol Surg. 2014 Nov;40(11):1201-7. doi: 10.1097/DSS.0000000000000157.
Onychomycosis is difficult to cure. Systemic and topical treatments, including the 1,064-nm Nd:YAG laser, are not very effective when used individually.
To compare the efficacy and safety of combined treatment with a long-pulsed 1,064-nm Nd:YAG laser and oral terbinafine with those of either treatment alone.
We randomly divided 53 patients with a total of 90 infected nails into 3 treatment groups: the T group received oral terbinafine, the L group received long-pulsed Nd:YAG laser treatment, and the T + L group received both treatments. We evaluated the mycological clearance rate (MCR) and the clinical clearance rate (CCR) of the 3 groups at Weeks 4, 8, 12, 16, and 24.
The MCR and CCR increased in all 3 groups in a time-dependent manner. The MCR and CCR of the T + L group were significantly higher than those of the T group and the L group at Weeks 8, 12, 16, and 24 (p < .05).
These data indicate that 12 weeks of combined treatment with a long-pulsed Nd:YAG laser and oral terbinafine produce more rapid and effective mycological and clinical clearance in patients with onychomycosis than either treatment alone, without any obvious side effects.
甲真菌病难以治愈。单独使用系统治疗和局部治疗(包括 1064nmNd:YAG 激光)效果并不理想。
比较长脉冲 1064nmNd:YAG 激光联合口服特比萘芬与单独治疗的疗效和安全性。
我们将 53 例共 90 个感染指甲的患者随机分为 3 个治疗组:T 组口服特比萘芬,L 组接受长脉冲 Nd:YAG 激光治疗,T+L 组接受两种治疗。我们在第 4、8、12、16 和 24 周评估 3 组的真菌清除率(MCR)和临床清除率(CCR)。
所有 3 组的 MCR 和 CCR 均随时间呈依赖性增加。在第 8、12、16 和 24 周时,T+L 组的 MCR 和 CCR 明显高于 T 组和 L 组(p<0.05)。
这些数据表明,12 周的长脉冲 Nd:YAG 激光联合口服特比萘芬治疗可使甲真菌病患者更快更有效地清除真菌和临床症状,且无明显不良反应。